ErysotrineCAS# 27740-43-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 27740-43-8 | SDF | Download SDF |
| PubChem ID | 442219 | Appearance | Oil |
| Formula | C19H23NO3 | M.Wt | 313.4 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2R,13bS)-2,11,12-trimethoxy-2,6,8,9-tetrahydro-1H-indolo[7a,1-a]isoquinoline | ||
| SMILES | COC1CC23C(=CCN2CCC4=CC(=C(C=C34)OC)OC)C=C1 | ||
| Standard InChIKey | WXVSPYOOFCCEII-KXBFYZLASA-N | ||
| Standard InChI | InChI=1S/C19H23NO3/c1-21-15-5-4-14-7-9-20-8-6-13-10-17(22-2)18(23-3)11-16(13)19(14,20)12-15/h4-5,7,10-11,15H,6,8-9,12H2,1-3H3/t15-,19-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Erysotrine does not show cytotoxic activity by itself, but exhibits significant cytotoxicity when combines with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). 2. (+)-Erysotrine shows potent dosedependant antifeedant activity at concentrations ≥100 ppm. |
| Targets | AChR |
Erysotrine Dilution Calculator
Erysotrine Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.1908 mL | 15.9541 mL | 31.9081 mL | 63.8162 mL | 79.7703 mL |
| 5 mM | 0.6382 mL | 3.1908 mL | 6.3816 mL | 12.7632 mL | 15.9541 mL |
| 10 mM | 0.3191 mL | 1.5954 mL | 3.1908 mL | 6.3816 mL | 7.977 mL |
| 50 mM | 0.0638 mL | 0.3191 mL | 0.6382 mL | 1.2763 mL | 1.5954 mL |
| 100 mM | 0.0319 mL | 0.1595 mL | 0.3191 mL | 0.6382 mL | 0.7977 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Scutellarin
Catalog No.:BCN5902
CAS No.:27740-01-8
- 2,4-Bis(α,α-dimethylbenzyl)phenol
Catalog No.:BCC8498
CAS No.:2772-45-4
- 7-Megastigmene-3,5,6,9-tetraol
Catalog No.:BCN5168
CAS No.:276870-26-9
- Cryptomoscatone D2
Catalog No.:BCN7203
CAS No.:276856-55-4
- WAY 161503 hydrochloride
Catalog No.:BCC7179
CAS No.:276695-22-8
- Akt/SKG Substrate Peptide
Catalog No.:BCC5748
CAS No.:276680-69-4
- Leucoside
Catalog No.:BCN5167
CAS No.:27661-51-4
- Cyanidin-3-O-galactoside chloride
Catalog No.:BCN3022
CAS No.:27661-36-5
- Boc-Ser-OMe
Catalog No.:BCC3441
CAS No.:2766-43-0
- 5-Isoquinolinesulfonic acid
Catalog No.:BCC8749
CAS No.:27655-40-9
- 15-Nonacosanol
Catalog No.:BCC8439
CAS No.:2764-81-0
- Muscimol
Catalog No.:BCC6593
CAS No.:2763-96-4
- Geniposidic acid
Catalog No.:BCN5171
CAS No.:27741-01-1
- Pahutoxin
Catalog No.:BCN1811
CAS No.:27742-14-9
- 5-Hydroxy-1-methoxyxanthone
Catalog No.:BCN6575
CAS No.:27770-13-4
- Ervamycine
Catalog No.:BCN5172
CAS No.:27773-39-3
- 9-Angeloylretronecine N-oxide
Catalog No.:BCN2037
CAS No.:27773-86-0
- Uncarinic acid E
Catalog No.:BCN6774
CAS No.:277751-61-8
- Loroquine
Catalog No.:BCN2008
CAS No.:27792-82-1
- UDP disodium salt
Catalog No.:BCC7570
CAS No.:27821-45-0
- Sunset yellow
Catalog No.:BCN2222
CAS No.:2783-94-0
- Serratenediol diacetate
Catalog No.:BCN5173
CAS No.:27832-84-4
- Loxapine Succinate
Catalog No.:BCC4674
CAS No.:27833-64-3
- Macrophylline
Catalog No.:BCN1987
CAS No.:27841-97-0
Anti-HIV-1 and cytotoxicity of the alkaloids of Erythrina abyssinica Lam. growing in Sudan.[Pubmed:21936641]
Nat Prod Res. 2012;26(17):1565-75.
Erythrina abyssinica Lam. is an important medicinal plant growing in Sudan; its seeds were investigated for the first time for their alkaloidal constituents and biological activity. The in vitro cytotoxicity of the crude alkaloidal fraction (CAF) against the cell lines HeLa, Hep-G2, HEP-2, HCT116, MCF-7 and HFB4 showed promising activity, with IC(5)(0) values of 13.8, 10.1, 8.16, 13.9, 11.4 and 12.2 microg mL(-)(1), respectively. Doxorubicin (positive control) showed in vitro cytotoxic activity with IC(5)(0) values 3.64, 4.57, 4.89, 3.74, 2.97 and 3.96 microg mL(-)(1), respectively. Bioassay-guided fractionation and isolation of the CAF led to the isolation of five Erythrina alkaloids, identified as erythraline, erysodine, Erysotrine, 8-oxoerythraline and 11-methoxyerysodine. These were evaluated for their in vitro cytotoxic activity against Hep-G2 which resulted in IC(5)(0) values 17.60, 11.80, 15.80, 3.89 and 11.40 microg mL(-)(1), respectively. Furthermore, in vitro cytotoxic activity against HEP-2 was evaluated, which resulted in IC(5)(0) values 15.90, 19.90, 21.60, 18.50 and 11.50 microg mL(-)(1), respectively. The CAF caused a reduction in the viability of mock-infected MT-4 cells with a CC(5)(0) of 53 microM and a 50% protection of MT-4 cells against HIV-1 induced cytopathogeneticy with a EC(5)(0) of >53 microM, compared with EFV as a positive control, which had a CC(5)(0) of 45 microM and an EC(5)(0) of 0.003 microM. We concluded that the isolated alkaloids were responsible for the anti-carcinogenic [corrected] actions of the plant extract previously reported in the literature.
TRAIL-enhancing activity of Erythrinan alkaloids from Erythrina velutina.[Pubmed:19026536]
Bioorg Med Chem Lett. 2009 Jan 1;19(1):234-6.
A new Erythrinan alkaloid (1), erythodine N-oxide, was isolated from the seeds of Erythrina velutina together with seven known Erythrinan alkaloids (2-7, 9) and an indole alkaloid (8). The structure of new compound (1) was elucidated by spectroscopic methods. Six of the nine compounds showed enhanced activity when combined with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Erysotrine (4) did not show cytotoxic activity by itself, but exhibited significant cytotoxicity when combined with TRAIL.
